Ticagrelor and aspirin is the preferred combination for reducing the risk of recurrent stroke in clopidogrel nonresponders, but according to post hoc analysis of the CHANCE-2 trial, patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback